Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

NCT01011751 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

311

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma, Prostate

Interventions

DRUG: Cyproterone acetate
DRUG: Medroxyprogesterone acetate
DRUG: Venlafaxine
DRUG: Leuprorelin
DRUG: Flutamide
DRUG: Placebo

Sponsor

Takeda